{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T20:17:54Z","timestamp":1788034674156,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010559","name":"Children&apos;s Hospital of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016477","name":"CareDx","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016477","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.healun.2026.07.036","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T06:37:45Z","timestamp":1786084665000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Daratumumab for non-acute antibody-mediated rejection after pediatric heart transplantation: Treatment response in the presence and absence of circulating HLA donor-specific antibody"],"prefix":"10.1016","author":[{"given":"Yuen","family":"Lo Yau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0579-1924","authenticated-orcid":false,"given":"Qingyong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2483-1058","authenticated-orcid":false,"given":"Matthew D.","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Rose-Felker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn C.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-5016","authenticated-orcid":false,"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4244-709X","authenticated-orcid":false,"given":"Brian","family":"Feingold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.healun.2026.07.036_bib1","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.1003032","article-title":"Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors","volume":"186","author":"de Weers","year":"2011","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.healun.2026.07.036_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/petr.70106","article-title":"Daratumumab for Anti-HLA Antibody Desensitization and Antibody Mediated Rejection in Pediatric Heart Transplant Patients","volume":"29","author":"Milligan","year":"2025","journal-title":"Pediatr Transplant"},{"issue":"10","key":"10.1016\/j.healun.2026.07.036_bib3","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.healun.2022.06.017","article-title":"Daratumumab provides transient response of antibody mediated rejection post pediatric orthotopic heart transplantation","volume":"41","author":"Fenton","year":"2022","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.healun.2026.07.036_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/petr.70166","article-title":"Daratumumab in Heart Transplantation: A Pilot Study in a Pediatric and Young Adult Series","volume":"29","author":"Tuta","year":"2025","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1016\/j.healun.2026.07.036_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/petr.70168","article-title":"Donor-Derived Cell-Free DNA as a Marker for the Efficacy of Daratumumab in Patients With Antibody-Mediated Rejection Post-Heart Transplantation: A Case Series","volume":"29","author":"Konduri","year":"2025","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.healun.2026.07.036_bib6","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/TP.0000000000003505","article-title":"Daratumumab for Antibody-mediated Rejection in Heart Transplant \u2014 A Novel Therapy: Successful Treatment of Antibody-mediated Rejection","volume":"105","author":"Aguilera Agudo","year":"2021","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.healun.2026.07.036_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.healun.2026.07.036_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIRCULATIONAHA.123.068189","article-title":"Waitlist Outcomes for Pediatric Heart Transplantation in the Current Era: An Analysis of the Pediatric Heart Transplant Society Database","volume":"150","author":"Butts","year":"2024","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.healun.2026.07.036_bib9","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.healun.2016.04.007","article-title":"The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection","volume":"35","author":"Clerkin","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.healun.2026.07.036_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1747-0803.2011.00601.x","article-title":"Pediatric coronary allograft vasculopathy \u2014 a review of pathogenesis and risk factors","volume":"7","author":"Schumacher","year":"2012","journal-title":"Congenit Heart Dis"},{"issue":"12","key":"10.1016\/j.healun.2026.07.036_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011592","article-title":"Redefining Cardiac Antibody-Mediated Rejection With Donor-Specific Antibodies and Graft Dysfunction","volume":"17","author":"Goldberg","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2026.07.036_bib12","article-title":"Enhanced detection of antibody-mediated rejection using the tissue-based Molecular Microscope Diagnostic System (MMDx)","author":"Fernandez Valledor","year":"2025","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.healun.2026.07.036_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14705","article-title":"Histopathology, mRNA expression profile, and donor-derived cell-free DNA for assessment of rejection in pediatric heart transplantation","volume":"28","author":"O'Halloran","year":"2024","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.healun.2026.07.036_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.healun.2026.07.036_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14933","article-title":"Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation","volume":"37","author":"Feingold","year":"2023","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.healun.2026.07.036_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/TP.0000000000004323","article-title":"The Molecular Microscope Diagnostic System: Assessment of Rejection and Injury in Heart Transplant Biopsies","volume":"107","author":"Halloran","year":"2023","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.healun.2026.07.036_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1042\/CS20220530","article-title":"Precision diagnostics in transplanted organs using microarray-assessed gene expression: concepts and technical methods of the Molecular Microscope\u00ae Diagnostic System (MMDx)","volume":"138","author":"Madill-Thomsen","year":"2024","journal-title":"Clin Sci (Lond)"},{"issue":"8","key":"10.1016\/j.healun.2026.07.036_bib18","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ajt.2024.03.031","article-title":"Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival","volume":"24","author":"Halloran","year":"2024","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.healun.2026.07.036_bib19","first-page":"587","article-title":"A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation","volume":"9","author":"Billingham","year":"1990","journal-title":"J Heart Transplant"},{"issue":"11","key":"10.1016\/j.healun.2026.07.036_bib20","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"issue":"12","key":"10.1016\/j.healun.2026.07.036_bib21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"18","key":"10.1016\/j.healun.2026.07.036_bib22","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIR.0000000000000093","article-title":"Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association","volume":"131","author":"Colvin","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.healun.2026.07.036_bib23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.healun.2026.07.036_bib24","article-title":"Contemporary Antibody-Mediated Rejection in Heart Transplantation","volume":"13","author":"Mehta","year":"2025","journal-title":"JACC Heart Fail Position Statement JACC Heart Fail"},{"issue":"5","key":"10.1016\/j.healun.2026.07.036_bib25","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1053\/j.ajkd.2022.11.010","article-title":"Daratumumab Use Prior to Kidney Transplant and T Cell-Mediated Rejection: A Case Report","volume":"81","author":"Scalzo","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.healun.2026.07.036_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1087597","article-title":"Case report: Daratumumab for treatment of refractory late or chronic active antibody-mediated rejection in renal allograft recipients with high levels of de novo donor-specific antibodies","volume":"13","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.healun.2026.07.036_bib27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood-2015-12-687749","article-title":"Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma","volume":"128","author":"Krejcik","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.healun.2026.07.036_bib28","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3390\/biomedicines10071506","article-title":"Non-HLA Antibodies in Kidney Transplantation: Immunity and Genetic Insights","volume":"10","author":"Sorohan","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.healun.2026.07.036_bib29","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1111\/ajt.15871","article-title":"Profiling non-HLA antibody responses in antibody-mediated rejection following heart transplantation","volume":"20","author":"See","year":"2020","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.healun.2026.07.036_bib30","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1111\/ajt.15863","article-title":"Discovery of non-HLA antibodies associated with cardiac allograft rejection and development and validation of a non-HLA antigen multiplex panel: From bench to bedside","volume":"20","author":"Butler","year":"2020","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.healun.2026.07.036_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13416","article-title":"De novo donor-specific HLA antibodies in heart transplantation: Do transient de novo DSA confer the same risk as persistent de novo DSA?","volume":"32","author":"Moayedi","year":"2018","journal-title":"Clin Transplant"},{"issue":"11","key":"10.1016\/j.healun.2026.07.036_bib32","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1111\/ajt.16690","article-title":"The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation","volume":"21","author":"Lin","year":"2021","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.healun.2026.07.036_bib33","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1681\/ASN.2020111558","article-title":"Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study","volume":"32","author":"Callemeyn","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.healun.2026.07.036_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1681\/ASN.2020040433","article-title":"Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection","volume":"32","author":"Koenig","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.healun.2026.07.036_bib35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3390\/cells9010228","article-title":"Roles of CD38 in the Immune Response to Infection","volume":"9","author":"Glar\u00eda","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.healun.2026.07.036_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.597959","article-title":"CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity","volume":"11","author":"Piedra-Quintero","year":"2020","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.healun.2026.07.036_bib37","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302214","article-title":"B-cell targeting with anti-CD38 daratumumab: implications for differentiation and memory responses","volume":"6","author":"Verhoeven","year":"2023","journal-title":"Life Sci Alliance"},{"issue":"3","key":"10.1016\/j.healun.2026.07.036_bib38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.healun.2021.08.004","article-title":"Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes","volume":"41","author":"Halloran","year":"2022","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.healun.2026.07.036_bib39","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41385-018-0050-3","article-title":"The current state of the art for biological therapies and new small molecules in inflammatory bowel disease","volume":"11","author":"Paramsothy","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.healun.2026.07.036_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211035542","article-title":"Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders","volume":"14","author":"Brummer","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"issue":"10","key":"10.1016\/j.healun.2026.07.036_bib41","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.healun.2022.07.019","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth pediatric heart transplantation report \u2014 2022; focus on infant heart transplantation","volume":"41","author":"Singh","year":"2022","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.healun.2026.07.036_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13981","article-title":"The complication rate of intravascular ultrasound (IVUS) in a multicenter pediatric heart transplant population: A study of the international pediatric IVUS consortium","volume":"34","author":"Auerbach","year":"2020","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.healun.2026.07.036_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14523","article-title":"Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation","volume":"36","author":"Reddy","year":"2022","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1016\/j.healun.2026.07.036_bib44","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jcmg.2025.05.019","article-title":"Cardiac CT and PET for Surveillance of Heart Transplant Recipients: Systematic Review and Bayesian Meta-Analysis","volume":"18","author":"Sayed","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.healun.2026.07.036_bib45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/eurheartj\/ehx683","article-title":"Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy","volume":"39","author":"Bravo","year":"2018","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.healun.2026.07.036_bib46","article-title":"Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens","volume":"13","author":"De Novellis","year":"2024","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.healun.2026.07.036_bib47","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1016\/j.clml.2021.01.009","article-title":"Symptomatic BK Virus Disease in Patients With Heavily Pretreated Multiple Myeloma","volume":"21","author":"Lebel","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.healun.2026.07.036_bib48","article-title":"Humoral rejection in heart transplantation in the current era","volume":"11","author":"Sheridan","year":"2025","journal-title":"JHLT Open"},{"issue":"4","key":"10.1016\/j.healun.2026.07.036_bib49","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.healun.2017.03.013","article-title":"Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation","volume":"37","author":"Almond","year":"2018","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.healun.2026.07.036_bib50","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.3324\/haematol.2019.231860","article-title":"Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients","volume":"105","author":"Frerichs","year":"2020","journal-title":"Haematologica"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324982602036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324982602036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T19:47:06Z","timestamp":1788032826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105324982602036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S105324982602036X"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2026.07.036","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daratumumab for non-acute antibody-mediated rejection after pediatric heart transplantation: Treatment response in the presence and absence of circulating HLA donor-specific antibody","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2026.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}